With the rapid growth in molecular diagnostics and targeted treatments, cancer providers are able to deliver increasingly precise therapies that improve outcomes and reduce toxicities. However, to realize the benefits of personalized medicine, cancer providers have to make investments in laboratory capabilities, clinical decision support, rapid learning systems, patient education, and clinician training.
Use our top resources to help guide your personalized medicine strategy.